close
Öffnungszeiten: Mo. - Do. 08:00 bis 17:00 Uhr | Fr. 08:00 bis 14:00
Westdeutsches Prostatazentrum Logo
close

Neuer PSMA-Marker erhöht Treffergenauigkeit bei Prostatakrebs

Literatur / Quellen
  1. Afshar-Oromieh A, Zechmann CM, et al. :Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20. doi: 10.1007/s00259-013-2525-5. Epub 2013 Sep 27.
  2. Afshar-Oromieh A, Haberkorn U, et al: Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19.
  3. Souvatzoglou M, Krause BJ et al.:
  4. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer. Radiother Oncol. 2011 May;99(2):193-200. doi: 10.1016/j.radonc.2011.05.005. Epub 2011 May 26..
  5. Dietlein F, Kobe C, Neubauer S, Schmidt M, Stockter S, Fischer Th, Schomäcker K, Heidenreich A, Zlatopolskiy B, Neumaier, B, Drzezga A, Dietlein M PSA-stratified performance of 18F- and 68Ga-labeled tracers in PSMA-PET imaging of patients with biochemical recurrence of prostate cancer. J Nucl Med 2016